Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randy S Longman

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Journal of Crohn'S & Colitis|October 23, 2024
Multiomics Resolves Regulatory Mechanisms in a Diverse Cohort of Crohn's DiseaseRandy S Longman
Inflammatory Bowel Diseases|June 17, 2026
TL1A and DR3 in IBD: from mucosal immunopathology to a new era of targeted therapyRandy S Longman
Cellular and Molecular Gastroenterology and Hepatology|September 28, 2025
Cell Adhesion Molecule 1 Emerges as a Biomarker and Therapeutic Opportunity in Inflammatory Bowel DiseaseRandy S Longman
The Journal of Clinical Investigation|May 3, 2021
Decoding the matrix: multiomics reveals host-microbe biomarker for inflammatory bowel diseaseMonica Viladomiu, Randy S Longman
World Journal of Gastroenterology|March 30, 2013
Microbial manipulation as primary therapy for Crohn's diseaseRandy S Longman, Arun Swaminath
Cell Host & Microbe|January 14, 2021
A Diamond in the Rough: IgA-Seq Signatures Stratify New Onset IBDSvetlana Lima, Randy S Longman
The Journal of Experimental Medicine|April 10, 2024
Sounding the alarm in the lung with TL1ASilvia Pires, Randy S Longman
Current Opinion in Rheumatology|May 24, 2015
The functional impact of the intestinal microbiome on mucosal immunity and systemic autoimmunityRandy S Longman, Dan R Littman
Journal of Crohn'S & Colitis|October 31, 2021
Eating for Two: Diet and the Microbiome in Ulcerative ColitisSvetlana F Lima, Randy S Longman
The Journal of Clinical Investigation|June 11, 2019
The balance of power: innate lymphoid cells in tissue inflammation and repairJim G Castellanos, Randy S Longman
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Journal of Crohn'S & Colitis|October 23, 2024
Multiomics Resolves Regulatory Mechanisms in a Diverse Cohort of Crohn's DiseaseRandy S Longman
Inflammatory Bowel Diseases|June 17, 2026
TL1A and DR3 in IBD: from mucosal immunopathology to a new era of targeted therapyRandy S Longman
Cellular and Molecular Gastroenterology and Hepatology|September 28, 2025
Cell Adhesion Molecule 1 Emerges as a Biomarker and Therapeutic Opportunity in Inflammatory Bowel DiseaseRandy S Longman
The Journal of Clinical Investigation|May 3, 2021
Decoding the matrix: multiomics reveals host-microbe biomarker for inflammatory bowel diseaseMonica Viladomiu, Randy S Longman
World Journal of Gastroenterology|March 30, 2013
Microbial manipulation as primary therapy for Crohn's diseaseRandy S Longman, Arun Swaminath
Cell Host & Microbe|January 14, 2021
A Diamond in the Rough: IgA-Seq Signatures Stratify New Onset IBDSvetlana Lima, Randy S Longman
The Journal of Experimental Medicine|April 10, 2024
Sounding the alarm in the lung with TL1ASilvia Pires, Randy S Longman
Current Opinion in Rheumatology|May 24, 2015
The functional impact of the intestinal microbiome on mucosal immunity and systemic autoimmunityRandy S Longman, Dan R Littman
Journal of Crohn'S & Colitis|October 31, 2021
Eating for Two: Diet and the Microbiome in Ulcerative ColitisSvetlana F Lima, Randy S Longman
The Journal of Clinical Investigation|June 11, 2019
The balance of power: innate lymphoid cells in tissue inflammation and repairJim G Castellanos, Randy S Longman
Pageof 7